IL36G and asthma: IL-36γ levels were significantly higher in nonsevere and severe asthma patients compared to healthy controls (18.8 [18.8-362.2], 18.8 [18.8-270.8], and 18.8 [18.8-18.8]; nonsevere vs controls, P = .02 and severe vs controls, P = .03, respectively) (Fig 1, C).